This website uses technical, customisation and analytical cookies, both first-party and third-party, to anonymously facilitate browsing and analyse statistics on use of the website. Learn more
Search results
-
Pfizer and the Challenges of the Pharmaceutical Industry (A)
Renate Kratochvil; Phillip C. NellCase IVEY-9B19M076-EStrategyIn 2018, President of the United States, Donald Trump, criticized the company Pfizer Inc. (Pfizer) for increasing drug prices—which had been a strategic move by Pfizer in response to industry-wide challenges. This announcement highlighted the complex dynaStarting at €8.20
-
DeliverMeal Ivory Coast: Addressing Headquarters' Demands (Simplified Chinese Version)
Benoit Decreton; Phillip C. Nell; Alison E. HolmCase IVEY-9B17MC048-EStrategyIn 2015, DeliverMeal was a Norwegian online food delivery firm, mostly present in what could be considered emerging markets such as those in Africa. Founded in 2010, the company had experienced extremely rapid international expansion. DeliverMeal followed a global strategy, and standardized processes and turnkey solutions were provided from the headquarters to the subsidiaries.The local business development manager at DeliverMeal’s Ivory Coast su...Starting at €8.20
-
Aldi: The Dark Horse Discounter
Van Den Steen, Eric; Lane, DavidCase HBS-714474-EStrategyIn 2013, Aldi-the world's 8th largest retailer-planned to accelerate its US expansion. Aldi was a German-based hard discounter that sold a limited assortment of private-label groceries and household items in barebones stores. Despite its presence with 1200 stores in 32 states, Aldi was still relatively unknown in the US. But it was often cited as one of the reasons for Walmart's exit from Germany. Could it compete with Walmart in the US, Walmart'...Starting at €8.20
-
Social Business at Novartis: Arogya Parivar
Porter, Michael E.; Kramer, Mark R.; Lane, DavidCase HBS-715411-EStrategyLate in 2013, Novartis CEO Joseph Jimenez was considering how and whether to deepen the company's investment in Arogya Parivar, its profitable program that sold Novartis medicines in rural India, while expanding access to medicine and health information to millions of Indian villagers.Starting at €8.20
-
Loris
Zhang, Shunyuan; Narayandas, Das; Straaberg, Stacy; Lane, DavidCase HBS-524010-EStrategyIn December 2022, Loris's executive team considered their go-to-market strategy. Loris was an artificial intelligence (AI) software startup for the customer service industry with two products on the market: 1) Agent Assist which provided customer service agents (CSAs) with empathetic, on-brand responses to text-based live chat (live chat) conversations, and 2) Insights which provided customer experience (CX) leaders with CSA performance and custo...Starting at €8.20
-
The Dark Horse Discounter (Spanish version)
Van Den Steen, Eric; Lane, DavidCase HBS-717S06StrategyIn 2013, Aldi-the world's 8th largest retailer-planned to accelerate its US expansion. Aldi was a German-based hard discounter that sold a limited assortment of private-label groceries and household items in barebones stores. Despite its presence with 1200 stores in 32 states, Aldi was still relatively unknown in the US. But it was often cited as one of the reasons for Walmart's exit from Germany. Could it compete with Walmart in the US, Walmart'...Starting at €8.20
-
dcs plus: Romanian SaaS Firm Goes International - Teaching Note
Phillip C. NellTeaching Note IVEY-8B20M173-EStrategyTeaching Note for product 9B20M173.Starting at €0.00
-
dcs plus: Romanian SaaS Firm Goes International
Phillip C. NellCase IVEY-9B20M173-EEntrepreneurship, StrategyOn a cold Monday morning in January 2018, the founder and chief executive officer of dcs plus was sitting in a taxi on his way to catch a plane to Dubai, United Arab Emirates. In Dubai, he would be visiting the Middle East subsidiary of his company, a RomStarting at €8.20
-
Aperture Investors
Palepu, Krishna G.; Serafeim, George; Lane, DavidCase HBS-119053-EStrategyAperture Investors is a startup investment firm that seeks disrupt the asset management industry through competitive differentiation by charging investors primarily when its portfolio managers outperform the marketplace. Headed by Wall Street veteran Peter Kraus and backed with substantial and patient seed capital, Aperture seeks to attract both star portfolio managers and assets from mutual funds and hedge funds. Kraus believes that his innovati...Starting at €8.20
-
Managing a Severe Crisis: PharmaCorp in Ukraine
Phillip C. Nell; Renate Kratochvil; Patricia KlopfCase IVEY-9B17M085-EStrategyIn early 2015, the newly appointed country head of PharmaCorp’s operating unit in Ukraine faced internal and external challenges in managing the global pharmaceutical company’s operations in the crisis-ridden country. Since November 2013, Ukraine had undergone massive disruptions, including riots in Kiev, the annexation of Crimea by Russia, and a war in its easternmost region. Amid these economic and political turbulences, PharmaCorp Ukraine expe...Starting at €8.20